Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension.
暂无分享,去创建一个
L. Moreland | R. Schrohenloher | R. Shmerling | T. Woodworth | D. Trentham | K. Parker | K. Sewell | R. P. Bucy | W. Swartz | W. Sullivan